Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App





US Labs Increase COVID-19 Testing Capacity but Facing Shortage of Supplies, Finds NILA Survey

By LabMedica International staff writers
Posted on 06 Oct 2020
A survey of community and regional laboratories in the US has revealed a potential collective increase in COVID-19 testing capacity, although difficulties persist in accessing the necessary testing supplies. More...


The National Independent Laboratory Association (NILA St. Louis, MO, USA) conducted a survey of 12 twelve community and regional laboratories that revealed shortages of test kits, reagents, and other materials, such as plastic pipette tips, without which they were unable to perform the promised number of tests. In spite of an increase in their COVID-19 testing capacity, these labs do not have access to the supplies and materials necessary to perform critical COVID-19 tests. For example, one regional laboratory reported an allocation from a manufacturer of enough reagents to process 500 tests per day, although it has a capacity for performing at least 3,000 tests per day.

The NILA has stressed that speedy test results are critical for isolating infected patients and mitigating the spread of COVID-19. Community and regional laboratories report they can provide test results within one to two days which is significantly faster than the reported wait times experienced by most of the US population in recent weeks and months. According to the NILA, mitigating supply shortages will help increase the number of tests provided as well as the speed with which test results are delivered.

“The federal government must do whatever it can to help alleviate the testing supply shortages NILA members are experiencing,” said Mark Birenbaum, Ph.D., executive director, NILA. “We won’t emerge from this pandemic unless we focus on testing, and community and regional independent laboratories are key to scaling up our nation’s testing capacity. We have not seen transparency from the federal government regarding where test supplies are being allocated and how community labs can increase their access to these essential supplies.”

Related Links:
National Independent Laboratory Association


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
SARS-CoV-2 & Flu A/B RT-PCR Test
Mplex SARS-CoV-2+, Flu A, Flu B (C1) RT-PCR
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.